Pentobarbital will reduce the level or effect of pimavanserin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. Keep away from coadministration if at all possible. Watch for diminished pimavanserin efficacy. An increase in pimavanserin dosage may be essential. Contraindicated (1)pentobarbital will minimize the level or effect of https://marlborougho417vyb7.wikiworldstock.com/user